- Home
- ATHA vs PSHG Comparison
ATHA vs PSHG Comparison
Compare ATHA & PSHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- PSHG
- Stock Information
- Founded
- ATHA 2011
- PSHG 2010
- Country
- ATHA United States
- PSHG Greece
- Employees
- ATHA N/A
- PSHG N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- PSHG Marine Transportation
- Sector
- ATHA Health Care
- PSHG Consumer Discretionary
- Exchange
- ATHA Nasdaq
- PSHG Nasdaq
- Market Cap
- ATHA 21.0M
- PSHG 21.4M
- IPO Year
- ATHA 2020
- PSHG N/A
- Fundamental
- Price
- ATHA $0.53
- PSHG $1.72
- Analyst Decision
- ATHA Buy
- PSHG Strong Buy
- Analyst Count
- ATHA 4
- PSHG 1
- Target Price
- ATHA $11.25
- PSHG $6.50
- AVG Volume (30 Days)
- ATHA 235.4K
- PSHG 60.3K
- Earning Date
- ATHA 02-20-2025
- PSHG 03-06-2025
- Dividend Yield
- ATHA N/A
- PSHG N/A
- EPS Growth
- ATHA N/A
- PSHG N/A
- EPS
- ATHA N/A
- PSHG 1.51
- Revenue
- ATHA N/A
- PSHG $89,608,000.00
- Revenue This Year
- ATHA N/A
- PSHG N/A
- Revenue Next Year
- ATHA N/A
- PSHG N/A
- P/E Ratio
- ATHA N/A
- PSHG $1.14
- Revenue Growth
- ATHA N/A
- PSHG N/A
- 52 Week Low
- ATHA $0.41
- PSHG $1.61
- 52 Week High
- ATHA $4.30
- PSHG $2.58
- Technical
- Relative Strength Index (RSI)
- ATHA 41.88
- PSHG 42.17
- Support Level
- ATHA $0.52
- PSHG $1.75
- Resistance Level
- ATHA $0.57
- PSHG $1.92
- Average True Range (ATR)
- ATHA 0.04
- PSHG 0.10
- MACD
- ATHA -0.00
- PSHG -0.01
- Stochastic Oscillator
- ATHA 11.82
- PSHG 8.00
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About PSHG Performance Shipping Inc.
Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates eight Aframax tanker vessels.